About US
Contact us
-
Sanofi nabs OTC nod for Nasacort amid consumer healthcare pushSanofi's ($SNY) got a new OTC offering, and consumers will soon have a steroid-based nasal spray option in drugstore aisles. Friday, the FDA backed the sale of allergy medNasacortas anOTC med. It's a2013/10/15
-
How do U.S. drugs come to cost more? Let us count the waysFor a couple of years, GlaxoSmithKline ($GSK) CEOAndrew Wittyhas been assuring investors that the company's big-selling lung drugAdvairwould be tough for generics makers to knock off, even after the d2013/10/14
-
Roche to supersize biologics production to meet biologics' super forecastsSwiss drugmaker to invest nearly $900 million on facilities in U.S., Europe Swiss drugmaker Rochehas seen explosive growth for drugs like its new breast cancer drugKadcylaand says it needs a lot more2013/10/14
-
IPEC Foundation 2013 Award Winners AnnouncedThe IPECFoundation recently announced its 2013 Award Recipients, which will be presented on November 10 in San Antonio, Texas during the American Association of Pharmaceutical Scientists (AAPS) Annual2013/10/12
-
IPEC-Americas 2014 Meeting DatesIPEC-Americas has announced it's committee meeting dates for calendar year 2014. Also known within inner circles as "IPECWeek" when the various standing committees and sub-committees meet in Arlington2013/10/12
-
IPEC-Americas Elemental Impurities TemplateIPECAmericas, with input from theCoalition for Rational Implementation of the USP Elemental Impurities Requirements,has developed a standardized letter and template that pharmaceutical companies can u2013/10/11
-
2013 PhexTour （Pharma Excipients Technical Application National Tour Seminar) 4th station--Changsha and 5th station--Guiyang were successfully concluded2013 PhexTour （Pharma Excipients Technical Application National Tour Seminar) 4th station--Changsha and 5th station--Guiyang, were successfully concluded on 24 September at Jolly Hotel Changsha and 22013/10/11
-
Psoriasis study does little to help Pfizer with XeljanzAnalyst sees side effects putting off 'risk-averse dermatology community' Rheumatoid arthritistreatmentXeljanz, while expected to grow into a big seller for Pfizer ($PFE), hasn't had a fast start. Th2013/10/11
-
Merck Serono's new HQ taps open-office style to encourage innovationMerck Seronoopened its new global headquarters in Darmstadt, Germany, after shuttering a co-HQ in Geneva last year. The redesigned buildings onMerck KGaA's campus feature the sort of flexible work sta2013/10/10
-
Teva plots 5,000 more job cuts in $2B savings driveTeva Pharmaceutical Industries is already in the middle of a big cost-cutting push. And it's about to get bigger. The Israel-based generics giant ($TEVA) plans to lay off up to 5,000 people, or about2013/10/10